24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
24/07/2015
CVC: 20 Years Making Images Meaningful
17/07/2015
Presentation of the Industrial Ring 4.0 Project
13/07/2015
New International Success for B-Barcelona Consulting /BGC
02/07/2015
Creation of the Barcelona Institute of Science and Technology
26/06/2015
A Delegation From Porto Alegre Visits the Barcelona Synchrotron Park
17/06/2015
First light for PAU camera, designed to study dark energy